Preclinical evaluation of the engineered stem cell chemokine stromal cell-derived factor 1α analog in a translational ovine myocardial infarction model
- PMID: 24366171
- PMCID: PMC4137973
- DOI: 10.1161/CIRCRESAHA.114.302884
Preclinical evaluation of the engineered stem cell chemokine stromal cell-derived factor 1α analog in a translational ovine myocardial infarction model
Abstract
Rationale: After myocardial infarction, there is an inadequate blood supply to the myocardium, and the surrounding borderzone becomes hypocontractile.
Objective: To develop a clinically translatable therapy, we hypothesized that in a preclinical ovine model of myocardial infarction, the modified endothelial progenitor stem cell chemokine, engineered stromal cell-derived factor 1α analog (ESA), would induce endothelial progenitor stem cell chemotaxis, limit adverse ventricular remodeling, and preserve borderzone contractility.
Methods and results: Thirty-six adult male Dorset sheep underwent permanent ligation of the left anterior descending coronary artery, inducing an anteroapical infarction, and were randomized to borderzone injection of saline (n=18) or ESA (n=18). Ventricular function, geometry, and regional strain were assessed using cardiac MRI and pressure-volume catheter transduction. Bone marrow was harvested for in vitro analysis, and myocardial biopsies were taken for mRNA, protein, and immunohistochemical analysis. ESA induced greater chemotaxis of endothelial progenitor stem cells compared with saline (P<0.01) and was equivalent to recombinant stromal cell-derived factor 1α (P=0.27). Analysis of mRNA expression and protein levels in ESA-treated animals revealed reduced matrix metalloproteinase 2 in the borderzone (P<0.05), with elevated levels of tissue inhibitor of matrix metalloproteinase 1 and elastin in the infarct (P<0.05), whereas immunohistochemical analysis of borderzone myocardium showed increased capillary and arteriolar density in the ESA group (P<0.01). Animals in the ESA treatment group also had significant reductions in infarct size (P<0.01), increased maximal principle strain in the borderzone (P<0.01), and a steeper slope of the end-systolic pressure-volume relationship (P=0.01).
Conclusions: The novel, biomolecularly designed peptide ESA induces chemotaxis of endothelial progenitor stem cells, stimulates neovasculogenesis, limits infarct expansion, and preserves contractility in an ovine model of myocardial infarction.
Keywords: bioengineering; magnetic resonance imaging; myocardial infarction; translational research.
Figures








Similar articles
-
Stromal cell-derived factor-1alpha activation of tissue-engineered endothelial progenitor cell matrix enhances ventricular function after myocardial infarction by inducing neovasculogenesis.Circulation. 2010 Sep 14;122(11 Suppl):S107-17. doi: 10.1161/CIRCULATIONAHA.109.930404. Circulation. 2010. PMID: 20837901 Free PMC article.
-
Bioengineered analog of stromal cell-derived factor 1α preserves the biaxial mechanical properties of native myocardium after infarction.J Mech Behav Biomed Mater. 2019 Aug;96:165-171. doi: 10.1016/j.jmbbm.2019.04.014. Epub 2019 Apr 17. J Mech Behav Biomed Mater. 2019. PMID: 31035067 Free PMC article.
-
Sustained release of engineered stromal cell-derived factor 1-α from injectable hydrogels effectively recruits endothelial progenitor cells and preserves ventricular function after myocardial infarction.Circulation. 2013 Sep 10;128(11 Suppl 1):S79-86. doi: 10.1161/CIRCULATIONAHA.112.000343. Circulation. 2013. PMID: 24030424 Free PMC article.
-
CXCL12: a new player in coronary disease identified through human genetics.Trends Cardiovasc Med. 2010 Aug;20(6):204-9. doi: 10.1016/j.tcm.2011.08.002. Trends Cardiovasc Med. 2010. PMID: 22137643 Free PMC article. Review.
-
Assessment of Myocardial Diastolic Dysfunction as a Result of Myocardial Infarction and Extracellular Matrix Regulation Disorders in the Context of Mesenchymal Stem Cell Therapy.J Clin Med. 2022 Sep 15;11(18):5430. doi: 10.3390/jcm11185430. J Clin Med. 2022. PMID: 36143077 Free PMC article. Review.
Cited by
-
Natural Heart Regeneration in a Neonatal Rat Myocardial Infarction Model.Cells. 2020 Jan 16;9(1):229. doi: 10.3390/cells9010229. Cells. 2020. PMID: 31963369 Free PMC article.
-
Overexpression of hypoxia-inducible factor 1 alpha improves immunomodulation by dental mesenchymal stem cells.Stem Cell Res Ther. 2017 Sep 29;8(1):208. doi: 10.1186/s13287-017-0659-2. Stem Cell Res Ther. 2017. PMID: 28962641 Free PMC article.
-
A Bioengineered Neuregulin-Hydrogel Therapy Reduces Scar Size and Enhances Post-Infarct Ventricular Contractility in an Ovine Large Animal Model.J Cardiovasc Dev Dis. 2020 Nov 17;7(4):53. doi: 10.3390/jcdd7040053. J Cardiovasc Dev Dis. 2020. PMID: 33212844 Free PMC article.
-
The bifunctional SDF-1-AnxA5 fusion protein protects cardiac function after myocardial infarction.J Cell Mol Med. 2019 Nov;23(11):7673-7684. doi: 10.1111/jcmm.14640. Epub 2019 Aug 30. J Cell Mol Med. 2019. PMID: 31468674 Free PMC article.
-
An innovative biologic system for photon-powered myocardium in the ischemic heart.Sci Adv. 2017 Jun 14;3(6):e1603078. doi: 10.1126/sciadv.1603078. eCollection 2017 Jun. Sci Adv. 2017. PMID: 28630913 Free PMC article.
References
-
- Go AS, Mozaffarian D, Roger VL, Benjamin EJ, Berry JD, Borden WB, Bravata DM, Dai S, Ford ES, Fox CS, Franco S, Fullerton HJ, Gillespie C, Hailpern SM, Heit JA, Howard VJ, Huffman MD, Kissela BM, Kittner SJ, Lackland DT, Lichtman JH, Lisabeth LD, Magid D, Marcus GM, Marelli A, Matchar DB, McGuire DK, Mohler ER, Moy CS, Mussolino ME, Nichol G, Paynter NP, Schreiner PJ, Sorlie PD, Stein J, Turan TN, Virani SS, Wong ND, Woo D, Turner MB American Heart Association Statistics C; Stroke Statistics S. Heart disease and stroke statistics--2013 update: A report from the american heart association. Circulation. 2013;127:e6–e245. - PMC - PubMed
-
- Heidenreich PA, Trogdon JG, Khavjou OA, Butler J, Dracup K, Ezekowitz MD, Finkelstein EA, Hong Y, Johnston SC, Khera A, Lloyd-Jones DM, Nelson SA, Nichol G, Orenstein D, Wilson PW, Woo YJ American Heart Association Advocacy Coordinating C, Stroke C, Council on Cardiovascular R Intervention, Council on Clinical C, Council on E Prevention, Council on A, Thrombosis Vascular B, Council on C, Critical C, Perioperative, Resuscitation, Council on Cardiovascular N, Council on the Kidney in Cardiovascular D, Council on Cardiovascular S, Anesthesia, Interdisciplinary Council on Quality of C, Outcomes R. Forecasting the future of cardiovascular disease in the united states: A policy statement from the american heart association. Circulation. 2011;123:933–944. - PubMed
-
- Yankey GK, Li T, Kilic A, Cheng G, Satpute A, Savai K, Li S, Moainie SL, Prastein D, DeFillipi C, Wu ZJ, Griffith BP. Regional remodeling strain and its association with myocardial apoptosis after myocardial infarction in an ovine model. The Journal of thoracic and cardiovascular surgery. 2008;135:991–998. 998 e991-992. - PubMed
-
- Jackson BM, Gorman JH, Moainie SL, Guy TS, Narula N, Narula J, John-Sutton MG, Edmunds LH, Jr, Gorman RC. Extension of borderzone myocardium in postinfarction dilated cardiomyopathy. Journal of the American College of Cardiology. 2002;40:1160–1167. discussion 1168-1171. - PubMed
-
- Jayasankar V, Woo YJ, Bish LT, Pirolli TJ, Berry MF, Burdick J, Bhalla RC, Sharma RV, Gardner TJ, Sweeney HL. Inhibition of matrix metalloproteinase activity by timp-1 gene transfer effectively treats ischemic cardiomyopathy. Circulation. 2004;110:II180–186. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical